Certain Microfluidic Systems and Components Thereof and Products Containing Same; Commission's Final Determination Finding a Violation of Section 337; Issuance of a Limited Exclusion Order and Cease and Desist Order; and Termination of the Investigation, 9478-9479 [2020-03192]
Download as PDF
<![CDATA[
9478
Federal Register / Vol. 85, No. 33 / Wednesday, February 19, 2020 / Notices
support of the request to B. Sunday
Eiselt, Department of Anthropology,
Southern Methodist University, 3225
Daniel Avenue, Heroy Hall #450, Dallas,
TX 75205, telephone (214) 768–2915,
email seiselt@smu.edu, by March 20,
2020. After that date, if no additional
requestors have come forward, transfer
of control of the human remains to The
Tribes may proceed.
The Department of Anthropology,
Southern Methodist University is
responsible for notifying The Tribes that
this notice has been published.
Dated: January 21, 2020.
Melanie O’Brien,
Manager, National NAGPRA Program.
[FR Doc. 2020–03224 Filed 2–18–20; 8:45 am]
BILLING CODE 4312–52–P
DEPARTMENT OF THE INTERIOR
Office of Surface Mining Reclamation
and Enforcement
[S1D1S SS08011000 SX064A000
201S180110; S2D2S SS08011000
SX064A000 20XS501520; OMB Control
Number 1029–0116]
Agency Information Collection
Activities; Submission to the Office of
Management and Budget for Review
and Approval; Revisions; Renewal;
and Transfer, Assignment, or Sale of
Permit Rights
Office of Surface Mining
Reclamation and Enforcement, Interior.
ACTION: Notice of information collection;
request for comment.
AGENCY:
In accordance with the
Paperwork Reduction Act of 1995, we,
the Office of Surface Mining
Reclamation and Enforcement (OSMRE)
are proposing to renew an information
collection.
DATES: Interested persons are invited to
submit comments on or before March
20, 2020.
ADDRESSES: Send written comments on
this information collection request (ICR)
to the Office of Management and
Budget’s Desk Officer for the
Department of the Interior by email at
OIRA_Submission@omb.eop.gov; or via
facsimile to (202) 395–5806. Please
provide a copy of your comments to
Mark Gehlhar, Office of Surface Mining
Reclamation and Enforcement, 1849 C
Street NW, Room 4556–MIB,
Washington, DC 20240; or by email to
mgehlhar@osmre.gov. Please reference
OMB Control Number 1029–0116 in the
subject line of your comments.
FOR FURTHER INFORMATION CONTACT: To
request additional information about
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:51 Feb 18, 2020
Jkt 250001
this ICR, contact Mark Gehlhar by email
at mgehlhar@osmre.gov, or by telephone
at (202) 208–2716. You may also view
the ICR at https://www.reginfo.gov/
public/do/PRAMain.
SUPPLEMENTARY INFORMATION: In
accordance with the Paperwork
Reduction Act of 1995, we provide the
general public and other Federal
agencies with an opportunity to
comment on new, proposed, revised,
and continuing collections of
information. This helps us assess the
impact of our information collection
requirements and minimize the public’s
reporting burden. It also helps the
public understand our information
collection requirements and provide the
requested data in the desired format.
A Federal Register notice with a 60day public comment period soliciting
comments on this collection of
information was published on October
2, 2018 (83 FR 49570). No comments
were received.
We are again soliciting comments on
the proposed ICR that is described
below. We are especially interested in
public comment addressing the
following issues: (1) Is the collection
necessary to the proper functions of the
OSMRE; (2) will this information be
processed and used in a timely manner;
(3) is the estimate of burden accurate;
(4) how might the OSMRE enhance the
quality, utility, and clarity of the
information to be collected; and (5) how
might the OSMRE minimize the burden
of this collection on the respondents,
including through the use of
information technology.
Comments that you submit in
response to this notice are a matter of
public record. Before including your
address, phone number, email address,
or other personal identifying
information in your comment, you
should be aware that your entire
comment—including your personal
identifying information—may be made
publicly available at any time. While
you can ask us in your comment to
withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Abstract: Sections 506 and 511 of
Public Law 95–87 provide that persons
seeking permit revisions, renewals,
transfer, assignment, or sale of their
permit rights for coal mining activities
submit relevant information to the
regulatory authority to allow the
regulatory authority to determine
whether the applicant meets the
requirements for the action anticipated.
Title of Collection: Revisions;
Renewals; and Transfer, Assignment, or
Sale of Permit Rights.
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
OMB Control Number: 1029–0116.
Form Number: None.
Type of Review: Extension of a
currently approved collection.
Respondents/Affected Public: Surface
coal mining permit applicants and State
regulatory authorities.
Total Estimated Number of Annual
Respondents: Varies from 185 for sale of
permit rights to 2,188 for revisions from
permit applicants; and 182 for sale of
permit rights to 2,101 for revisions from
State regulatory authorities.
Total Estimated Number of Annual
Responses: 3,619 responses from permit
applicants and 3,511 responses from
State regulatory authorities.
Estimated Completion Time per
Response: Varies from 2 to 70 hours per
response for permit applicants; and 2 to
90 hours per response for State
regulatory authorities, depending on
permitting action.
Total Estimated Number of Annual
Burden Hours: 404,165 hours.
Respondent’s Obligation: Required to
obtain or retain a benefit.
Frequency of Collection: One time.
Total Estimated Annual Nonhour
Burden Cost: $909,758.
An agency may not conduct or
sponsor and a person is not required to
respond to a collection of information
unless it displays a currently valid OMB
control number.
The authority for this action is the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
Dated: February 12, 2020.
Mark J. Gehlhar,
Information Collection Clearance Officer,
Division of Regulatory Support.
[FR Doc. 2020–03169 Filed 2–18–20; 8:45 am]
BILLING CODE 4310–05–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–1100]
Certain Microfluidic Systems and
Components Thereof and Products
Containing Same; Commission’s Final
Determination Finding a Violation of
Section 337; Issuance of a Limited
Exclusion Order and Cease and Desist
Order; and Termination of the
Investigation
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the U.S. International Trade
Commission has determined that there
is a violation in the above-captioned
investigation. The Commission has
SUMMARY:
E:\FR\FM\19FEN1.SGM
19FEN1
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 85, No. 33 / Wednesday, February 19, 2020 / Notices
further determined to issue a limited
exclusion order and cease and desist
order and to set a bond rate on the
entered value of covered products
imported during the period of
Presidential review.
FOR FURTHER INFORMATION CONTACT:
Benjamin S. Richards, Esq., Office of the
General Counsel, U.S. International
Trade Commission, 500 E Street SW,
Washington, DC 20436, telephone (202)
708–5453. Copies of non-confidential
documents filed in connection with this
investigation are or will be available for
inspection during official business
hours (8:45 a.m. to 5:15 p.m.) in the
Office of the Secretary, U.S.
International Trade Commission, 500 E
Street SW, Washington, DC 20436,
telephone (202) 205–2000. General
information concerning the Commission
may also be obtained by accessing its
internet server at https://www.usitc.gov.
The public record for this investigation
may be viewed on the Commission’s
electronic docket (EDIS) at https://
edis.usitc.gov. Hearing-impaired
persons are advised that information on
this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810.
SUPPLEMENTARY INFORMATION: On
February 21, 2018, the Commission
instituted this investigation based on a
complaint filed by 10X Genomics, Inc.
of Pleasanton, CA. 83 FR 7491 (Feb. 21,
2018). The complaint alleges violations
of section 337 of the Tariff Act of 1930,
as amended, 19 U.S.C. 1337, in the
importation into the United States, the
sale for importation, or the sale within
the United States after importation of
certain microfluidic systems and
components thereof and products
containing same by reason of
infringement of one or more claims of
U.S. Patent Nos. 9,644,204 (‘‘the ’204
patent’’); 9,689,024 (‘‘the ’024 patent’’);
9,695,468 (‘‘the ’468 patent’’); and
9,856,530 (‘‘the ’530 patent’’). Id. The
Commission’s notice of investigation
named as the sole respondent Bio-Rad
Laboratories, Inc. of Hercules, CA. Id.
The Office of Unfair Import
Investigations (‘‘OUII’’) is participating
in this investigation. Id.
On July 12, 2019, the administrative
law judge (‘‘ALJ’’) issued the final initial
determination (‘‘ID’’). The ID found a
violation of section 337 by virtue of BioRad’s indirect infringement of the ’024,
the ’468, and the ’530 patents. The ID
found that 10X had not established a
violation with respect to the ’204 patent.
The ID also found that Bio-Rad failed to
establish invalidity of any of the
asserted claims of any patent. The ID
further found that the domestic industry
VerDate Sep<11>2014
17:51 Feb 18, 2020
Jkt 250001
requirement was satisfied for each of the
asserted patents. Finally, the ID found
that Bio-Rad had not carried its burden
with respect to various additional
affirmative defenses, including
improper inventorship and ownership.
On July 25, 2019, the ALJ issued her
recommended determination on remedy
and bonding. The ALJ recommended,
upon a finding of violation, that the
Commission issue a limited exclusion
order, issue a cease and desist order,
and impose a bond in the amount of
twenty-five percent of the entered value
of any covered products imported
during the period of Presidential review.
On July 29, 2019, 10X, Bio-Rad, and
OUII submitted petitions seeking review
of the ID. On August 6, 2019, 10X, BioRad, and OUII submitted responses to
the others’ petitions. On August 26,
2019, 10X and Bio-Rad submitted
comments on the public interest
pursuant to Commission Rule
210.50(a)(4).
On October 17, 2019, the Commission
issued a notice indicating its
determination to review the ID with
respect to (1) all findings related to a
violation based on the ’024 patent; (2)
all findings related to a violation based
on the ’468 patent; (3) noninfringement
of the ’204 patent; (4) all findings
related to a violation based on the ’530
patent; (5) Bio-Rad’s inventorship and
ownership defenses; and (6) a
typographical error on page 91. The
same notice also requested briefing from
the parties on certain of those issues,
and on remedy, bonding, and the public
interest. The notice also included an
extension of the target date to December
19, 2019.
The parties filed their initial
responses to the Commission’s
questions on October 31, 2019, and their
replies on November 7, 2019.
Upon review of the parties’
submissions, the ID, RD, and evidence
of record, the Commission has
determined that Bio-Rad violated
section 337 by reason of infringement of
asserted claims 1, 5, 17, 19, and 22 of
the ’024 patent, claims 1, 6, 7, 9, and 21
of the ’468 patent, and claims 1, 4, 11,
14, 19, 26, and 28 of the ’530 patent.
The Commission found no violation
with respect to the ’240 patent. The
Commission has further determined to
issue a limited exclusion order
prohibiting further importation of BioRad’s infringing microfluidic systems
and a cease and desist order against BioRad. The Commission will set a bond of
twenty-five percent of entered value on
Bio-Rad’s infringing microfluidic
systems imported during the period of
Presidential review.
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
9479
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR 210).
By order of the Commission.
Issued: February 12, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020–03192 Filed 2–18–20; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 332–574]
Renewable Electricity: Potential
Economic Effects of Increased
Commitments in Massachusetts;
Institution of Investigation and
Scheduling of Hearing
United States International
Trade Commission.
ACTION: Notice of investigation and
scheduling of a public hearing.
AGENCY:
Following receipt on January
23, 2020, of a request from the
Committee on Ways and Means
(Committee) of the U.S. House of
Representatives, under section 332(g) of
the Tariff Act of 1930, the U.S.
International Trade Commission
(Commission) instituted Investigation
No. 332–574, Renewable Electricity:
Potential Economic Effects of Increased
Commitments in Massachusetts, for the
purpose of providing a report regarding
the potential economic effects of
increased renewable energy
commitments in Massachusetts, and the
role of renewable electricity imports in
meeting these commitments.
DATES:
April 16, 2020: Deadline for filing
requests to appear at the public hearing.
April 23, 2020: Deadline for filing
prehearing briefs and statements.
May 7, 2020: Public hearing.
May 15, 2020: Deadline for filing posthearing briefs and statements.
July 28, 2020: Deadline for filing all
other written submissions.
January 25, 2021: Transmittal of
Commission report to the Committee.
ADDRESSES: All Commission offices,
including the Commission’s hearing
rooms, are located in the U.S.
International Trade Commission
Building, 500 E Street SW, Washington,
DC. All written submissions should be
addressed to the Secretary, U.S.
International Trade Commission, 500 E
Street SW, Washington, DC 20436. The
public record for this investigation may
SUMMARY:
E:\FR\FM\19FEN1.SGM
19FEN1
]]>Agencies
[Federal Register Volume 85, Number 33 (Wednesday, February 19, 2020)]
[Notices]
[Pages 9478-9479]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03192]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-1100]
Certain Microfluidic Systems and Components Thereof and Products
Containing Same; Commission's Final Determination Finding a Violation
of Section 337; Issuance of a Limited Exclusion Order and Cease and
Desist Order; and Termination of the Investigation
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the U.S. International Trade
Commission has determined that there is a violation in the above-
captioned investigation. The Commission has
[[Page 9479]]
further determined to issue a limited exclusion order and cease and
desist order and to set a bond rate on the entered value of covered
products imported during the period of Presidential review.
FOR FURTHER INFORMATION CONTACT: Benjamin S. Richards, Esq., Office of
the General Counsel, U.S. International Trade Commission, 500 E Street
SW, Washington, DC 20436, telephone (202) 708-5453. Copies of non-
confidential documents filed in connection with this investigation are
or will be available for inspection during official business hours
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S.
International Trade Commission, 500 E Street SW, Washington, DC 20436,
telephone (202) 205-2000. General information concerning the Commission
may also be obtained by accessing its internet server at https://www.usitc.gov. The public record for this investigation may be viewed
on the Commission's electronic docket (EDIS) at https://edis.usitc.gov.
Hearing-impaired persons are advised that information on this matter
can be obtained by contacting the Commission's TDD terminal on (202)
205-1810.
SUPPLEMENTARY INFORMATION: On February 21, 2018, the Commission
instituted this investigation based on a complaint filed by 10X
Genomics, Inc. of Pleasanton, CA. 83 FR 7491 (Feb. 21, 2018). The
complaint alleges violations of section 337 of the Tariff Act of 1930,
as amended, 19 U.S.C. 1337, in the importation into the United States,
the sale for importation, or the sale within the United States after
importation of certain microfluidic systems and components thereof and
products containing same by reason of infringement of one or more
claims of U.S. Patent Nos. 9,644,204 (``the '204 patent''); 9,689,024
(``the '024 patent''); 9,695,468 (``the '468 patent''); and 9,856,530
(``the '530 patent''). Id. The Commission's notice of investigation
named as the sole respondent Bio-Rad Laboratories, Inc. of Hercules,
CA. Id. The Office of Unfair Import Investigations (``OUII'') is
participating in this investigation. Id.
On July 12, 2019, the administrative law judge (``ALJ'') issued the
final initial determination (``ID''). The ID found a violation of
section 337 by virtue of Bio-Rad's indirect infringement of the '024,
the '468, and the '530 patents. The ID found that 10X had not
established a violation with respect to the '204 patent. The ID also
found that Bio-Rad failed to establish invalidity of any of the
asserted claims of any patent. The ID further found that the domestic
industry requirement was satisfied for each of the asserted patents.
Finally, the ID found that Bio-Rad had not carried its burden with
respect to various additional affirmative defenses, including improper
inventorship and ownership.
On July 25, 2019, the ALJ issued her recommended determination on
remedy and bonding. The ALJ recommended, upon a finding of violation,
that the Commission issue a limited exclusion order, issue a cease and
desist order, and impose a bond in the amount of twenty-five percent of
the entered value of any covered products imported during the period of
Presidential review.
On July 29, 2019, 10X, Bio-Rad, and OUII submitted petitions
seeking review of the ID. On August 6, 2019, 10X, Bio-Rad, and OUII
submitted responses to the others' petitions. On August 26, 2019, 10X
and Bio-Rad submitted comments on the public interest pursuant to
Commission Rule 210.50(a)(4).
On October 17, 2019, the Commission issued a notice indicating its
determination to review the ID with respect to (1) all findings related
to a violation based on the '024 patent; (2) all findings related to a
violation based on the '468 patent; (3) noninfringement of the '204
patent; (4) all findings related to a violation based on the '530
patent; (5) Bio-Rad's inventorship and ownership defenses; and (6) a
typographical error on page 91. The same notice also requested briefing
from the parties on certain of those issues, and on remedy, bonding,
and the public interest. The notice also included an extension of the
target date to December 19, 2019.
The parties filed their initial responses to the Commission's
questions on October 31, 2019, and their replies on November 7, 2019.
Upon review of the parties' submissions, the ID, RD, and evidence
of record, the Commission has determined that Bio-Rad violated section
337 by reason of infringement of asserted claims 1, 5, 17, 19, and 22
of the '024 patent, claims 1, 6, 7, 9, and 21 of the '468 patent, and
claims 1, 4, 11, 14, 19, 26, and 28 of the '530 patent. The Commission
found no violation with respect to the '240 patent. The Commission has
further determined to issue a limited exclusion order prohibiting
further importation of Bio-Rad's infringing microfluidic systems and a
cease and desist order against Bio-Rad. The Commission will set a bond
of twenty-five percent of entered value on Bio-Rad's infringing
microfluidic systems imported during the period of Presidential review.
The authority for the Commission's determination is contained in
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and
in part 210 of the Commission's Rules of Practice and Procedure (19 CFR
210).
By order of the Commission.
Issued: February 12, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020-03192 Filed 2-18-20; 8:45 am]
BILLING CODE 7020-02-P
